Advertisement
Canada markets closed
  • S&P/TSX

    24,471.17
    +168.91 (+0.70%)
     
  • S&P 500

    5,815.03
    +34.98 (+0.61%)
     
  • DOW

    42,863.86
    +409.74 (+0.97%)
     
  • CAD/USD

    0.7270
    -0.0008 (-0.11%)
     
  • CRUDE OIL

    75.49
    -0.36 (-0.47%)
     
  • Bitcoin CAD

    86,529.24
    +3,854.98 (+4.66%)
     
  • XRP CAD

    0.74
    +0.02 (+2.08%)
     
  • GOLD FUTURES

    2,674.20
    +34.90 (+1.32%)
     
  • RUSSELL 2000

    2,234.41
    +45.99 (+2.10%)
     
  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     
  • NASDAQ

    18,342.94
    +60.89 (+0.33%)
     
  • VOLATILITY

    20.46
    -0.47 (-2.25%)
     
  • FTSE

    8,253.65
    +15.92 (+0.19%)
     
  • NIKKEI 225

    39,605.80
    +224.91 (+0.57%)
     
  • CAD/EUR

    0.6642
    -0.0011 (-0.17%)
     

AngioDynamics: Fiscal Q4 Earnings Snapshot

LATHAM, N.Y. (AP) — LATHAM, N.Y. (AP) — AngioDynamics Inc. (ANGO) on Tuesday reported a loss of $13.4 million in its fiscal fourth quarter.

On a per-share basis, the Latham, New York-based company said it had a loss of 33 cents. Losses, adjusted for one-time gains and costs, were 6 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.

The medical device maker posted revenue of $71 million in the period.

For the year, the company reported that its loss widened to $184.3 million, or $4.59 per share. Revenue was reported as $303.9 million.

AngioDynamics expects full-year results to range from a loss of 42 cents per share to a loss of 38 cents per share, with revenue in the range of $282 million to $288 million.

AngioDynamics shares have decreased 24% since the beginning of the year. The stock has decreased 39% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANGO at https://www.zacks.com/ap/ANGO